Debjit Chattopadhyay
Stock Analyst at Guggenheim
(0)
# 4351
Out of 5,270 analysts
99
Total ratings
33.96%
Success rate
-11.47%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Beam Therapeutics | Reiterates: Buy | 78 78 | 25.08 | 211% | 2 | Feb 27, 2025 | |
Maze Therapeutics | Initiates Coverage On: Buy | 19 | 11.08 | 71.48% | 1 | Feb 25, 2025 | |
Rezolute | Reiterates: Buy | n/a | n/a | n/a | 2 | Feb 10, 2025 | |
Centessa Pharmaceuti... | Reiterates: Buy | n/a | n/a | n/a | 5 | Feb 10, 2025 | |
Dyne Therapeutics | Reiterates: Buy | n/a | n/a | n/a | 4 | Jan 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | n/a | n/a | n/a | 5 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 18 18 | 2.23 | 707.17% | 3 | Dec 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 17 17 | 12.52 | 35.78% | 2 | Dec 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 13 15 | 9.13 | 64.29% | 2 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 70 65 | 32.54 | 99.75% | 3 | Oct 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 450 558 | 483.3 | 15.46% | 6 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Neutral | n/a | n/a | n/a | 1 | Jun 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 19 | 5.05 | 276.24% | 2 | Apr 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 22 | 3.9 | 464.1% | 1 | Mar 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 130 175 | 171.51 | 2.03% | 3 | Feb 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 30 | 20.2 | 48.51% | 1 | Jan 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Buy | 40 | 45.77 | -12.61% | 1 | Nov 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 110 | 71.05 | 54.82% | 3 | Sep 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 43 29 | 1.8 | 1511.11% | 1 | Nov 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 13 11 | 0.48 | 2191.67% | 2 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 50 | 41.14 | 21.54% | 2 | Oct 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 1 | Jun 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 35 51 | n/a | n/a | 4 | Jan 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 28 | 1.6 | 1650% | 1 | Dec 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 170 | 9.45 | 1698.94% | 1 | Oct 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 260 | n/a | n/a | 1 | Jun 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 255 | n/a | n/a | 1 | May 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Buy | 20 | 10.09 | 98.22% | 2 | Dec 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Buy | 11 | n/a | n/a | 5 | Dec 4, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 260 221 | 101.19 | 118.4% | 4 | Aug 31, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 270 123 | 25.93 | 374.35% | 8 | Aug 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 60 54 | 12.64 | 327.22% | 3 | Jul 9, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 420 156 | n/a | n/a | 3 | Mar 31, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 60 | 1.74 | 3348.28% | 3 | Dec 3, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 75 90 | n/a | n/a | 5 | Nov 26, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 18 4 | n/a | n/a | 2 | Mar 4, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 3 | Jun 26, 2017 |